Kenneth J. Skeith
About
In The Last Decade
Kenneth J. Skeith
20 papers receiving 856 citations
Peers
Comparison fields: 5 of 103
- Rheumatology 345
- Pharmacology 237
- Oncology 132
- Immunology 125
- Pharmacology 119
Countries citing papers authored by Kenneth J. Skeith
This map shows the geographic impact of Kenneth J. Skeith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth J. Skeith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth J. Skeith more than expected).
Fields of papers citing papers by Kenneth J. Skeith
This network shows the impact of papers produced by Kenneth J. Skeith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth J. Skeith. The network helps show where Kenneth J. Skeith may publish in the future.
Co-authorship network of co-authors of Kenneth J. Skeith
This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth J. Skeith. A scholar is included among the top collaborators of Kenneth J. Skeith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth J. Skeith. Kenneth J. Skeith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 33 | |
| 2 | 158 | |
| 3 | 128 | |
| 4 | 101 | |
| 5 | 116 | |
| 6 | Topical diclofenac versus placebo: a double blind, randomized clinical trial in patients with osteoarthritis of the knee. | 84 |
| 7 | 29 | |
| 8 | An open study of pamidronate in the treatment of refractory ankylosing spondylitis. | 71 |
| 9 | 5 | |
| 10 | 12 | |
| 11 | 25 | |
| 12 | 28 | |
| 13 | 20 | |
| 14 | 5 | |
| 15 | 10 | |
| 16 | Serum cytidine deaminase as a measure of disease activity in rheumatoid arthritis and systemic lupus erythematosus. | 5 |
| 17 | 22 | |
| 18 | 2 | |
| 19 | 8 | |
| 20 | Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis. | 35 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.